MTOR.md
... ...
@@ -1,4 +1,6 @@
1 1
# MTOR
2
+## Overview
3
+Although mutations in MTOR have been reported in DLBCL<sup>1</sup> and some BL, their role in lymphomagenesis has not been thoroughly studied.
2 4
3 5
## Relevance tier by entity
4 6
... ...
@@ -45,5 +47,10 @@ View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAM
45 47
View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/MTOR.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/MTOR_hg38.html)
46 48
47 49
![image](images/proteinpaint/MTOR.svg)
50
+
48 51
## MTOR Expression
49 52
![image](images/gene_expression/MTOR_by_pathology.svg)
53
+
54
+## References
55
+
56
+1. *Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1398-403. doi: 10.1073/pnas.1205299110. Epub 2013 Jan 4. PMID: 23292937; PMCID: PMC3557051.*
... ...
\ No newline at end of file